About
Technology
Issues
FAQ
Links
Official Page
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.